U.S. FDA approves Sanofi's MS drug Lemtrada

November 15, 2014 3:23 PM

28 0

PARIS (Reuters) - The U.S. Food and Drug Administration has approved Sanofi's multiple sclerosis treatment Lemtrada, Sanofi said in a statement on Saturday.

Lemtrada is already sold in Europe but last December U.S. regulators rejected it on security concerns, prompting analysts to slash their global sales forecasts for the drug.

Also read: University of Oklahoma president says $1B debt not uncommon

Read more

To category page